Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Nature Biotechnology

• Publication date

  2018-04-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nbt.4148PMID 29702637
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evolved Cas9 variants with broad PAM compatibility and high DNA specificity

  2018cited by this paper
• Deaminase-mediated multiplex genome editing in Escherichia coli

  2018cited by this paper
• A communal catalogue reveals Earth’s multiscale microbial diversity

  2017cited by this paper
• Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions

  2017cited by this paper
• Generation of Targeted Point Mutations in Rice by a Modified CRISPR/Cas9 System.

  2017cited by this paper
• Highly efficient RNA-guided base editing in mouse embryos

  2017cited by this paper
• Genome-wide target specificities of CRISPR RNA-guided programmable deaminases

  2017cited by this paper
• Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems

  2016cited by this paper
• Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

  2016cited by this paper
• Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy

  2016cited by this paper
• In vivo gene editing in dystrophic mouse muscle and muscle stem cells

  2016cited by this paper
• Teleseismic S wave microseisms

  2016cited by this paper
• In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy

  2016cited by this paper
• Targeted mutagenesis in mice by electroporation of Cpf1 ribonucleoproteins

  2016cited by this paper
• Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases

  2014cited by this paper
• Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases

  2014cited by this paper
• Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double‐knockout mice

  2013cited by this paper
• Marginal Level Dystrophin Expression Improves Clinical Outcome in a Strain of Dystrophin/Utrophin Double Knockout Mice

  2010cited by this paper
• Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors

  2005cited by this paper
• Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization

  2000cited by this paper
• Molecular basis of mouse Himalayan mutation.

  1989cited by this paper
• HIMALAYAN, A NEW ALLELE OF ALBINO IN THE MOUSE

  1961cited by this paper

• ABE9 fused to SpRY Cas9 nickase enables precise generation of bystander free mouse models

  2026influential citation
• Base editing rescues seizures and sudden death in a SCN8A mutation-associated developmental epileptic encephalopathy model

  2026cites this paper
• Gene Editing for Duchenne Muscular Dystrophy: From Experimental Models to Emerging Therapies

  2025cites this paper
• Adenine base editing rescues pathogenic phenotypes in tissue engineered vascular model of Hutchinson-Gilford progeria syndrome

  2025cites this paper
• CRISPR-Cas editing technologies for viral-mediated gene therapies of human diseases: Mechanisms, progress, and challenges

  2025cites this paper
• Exploring new therapeutics for Duchenne muscular dystrophy and related cardiomyopathy

  2025cites this paper
• CRISPR-based functional genomics tools in vertebrate models

  2025cites this paper
• Targeting cellular senescence in dystrophin−/−/utrophin−/−double knockout mice improves musculoskeletal health and increases lifespan

  2025cites this paper
• An innovative approach using CRISPR-ribonucleoprotein packaged in virus-like particles to generate genetically engineered mouse models

  2025influential citation
• Preclinical development of genome editing to treat Duchenne muscular dystrophy by exon skipping

  2025cites this paper
• A motif preferred adenine base editor with minimal bystander and off-targets editing

  2025cites this paper
• Precision rewriting of muscle genetics: therapeutic horizons of base and prime editing in skeletal muscle disorders.

  2025cites this paper
• Targeting EP2 Receptor Improves Muscle and Bone Health in Dystrophin−/−/Utrophin−/− Double-Knockout Mice

  2025cites this paper
• Label-free Detection of Urine Extracellular Vesicles from Duchenne Muscular Dystrophy Patients Using Surface-Enhanced Raman Spectroscopy Combined with Machine Learning Models

  2025cites this paper
• GFP-on mouse model for interrogation of in vivo gene editing

  2025cites this paper
• Evaluation and prediction of guide RNA activities in genome-editing tools

  2025cites this paper
• CRISPR-Cas technologies: Emerging tools from research to clinical application.

  2025cites this paper
• BioFuse: A programmable timer switch of gene expression

  2025cites this paper
• Precise generation of bystander-free mouse models with ABE9-SpRY

  2025influential citation
• In vivo delivery systems for CRISPR genome editing: Viral and non-viral carriers

  2025cites this paper
• Engineering adeno-associated viral vectors for CRISPR/Cas based in vivo therapeutic genome editing.

  2025cites this paper
• Efforts to Downsize Base Editors for Clinical Applications

  2025cites this paper
• Prospects for using gene therapy drugs in the treatment of cystic fibrosis

  2025cites this paper
• CURRENT STATUS AND PROSPECTS OF GENOME EDITING TECHNOLOGIES

  2025cites this paper
• Dual SORT LNPs for multi-organ base editing.

  2025cites this paper
• Genetic strategies for therapy of Duchenne muscular dystrophy

  2025cites this paper
• Research progress of base editing and prime editing tools based on the CRISPR/Cas system

  2025cites this paper
• Therapeutic in vivo genome editing: innovations and challenges in rAAV vector-based CRISPR delivery

  2025cites this paper
• Gene therapy for genetic diseases: challenges and future directions

  2025cites this paper
• Optimized dual-AAV base editor delivery system with enhanced editing efficiency and virion production titer

  2025cites this paper
• Current Trends in Gene Therapy to Treat Inherited Disorders of the Brain.

  2025cites this paper
• Prime Editing: A Revolutionary Technology for Precise Treatment of Genetic Disorders

  2025cites this paper
• CRISPR-dependent base editing as a therapeutic strategy for rare monogenic disorders

  2025cites this paper
• Comprehensive strategies for constructing efficient CRISPR/Cas based cancer therapy: Target gene selection, sgRNA optimization, delivery methods and evaluation.

  2025cites this paper
• Efficient AAV8 delivery to the liver via isolated hepatic perfusion and analysis of hepatic lobule transduction patterns

  2025cites this paper
• In vivo precision base editing to rescue mouse models of disease

  2025cites this paper
• Advancing gene editing therapeutics: Clinical trials and innovative delivery systems across diverse diseases

  2025cites this paper
• Overcoming the Delivery Challenges in CRISPR/Cas9 Gene Editing for Effective Cancer Treatment: A Review of Delivery Systems

  2025cites this paper
• In vivo base editing reduces liver cysts in autosomal dominant polycystic kidney disease

  2025cites this paper
• Engineering Targeted Gene Delivery Systems for Primary Hereditary Skeletal Myopathies: Current Strategies and Future Perspectives

  2025cites this paper
• Bridging biomedicine and technology: the impact of AI & GenAI in life sciences and agribusiness.

  2025cites this paper
• New insights into applications of base editor in hereditary disorders

  2025cites this paper
• The Interface of Gene Editing with Regenerative Medicine

  2024cites this paper
• Optimal protospacer sequences recommended by ensemble deep learning for high-efficiency base editing

  2024cites this paper
• Advanced cell and gene therapies in cardiology

  2024cites this paper
• Insights into Prime Editing Technology: A Deep Dive into Fundamentals, Potentials, and Challenges

  2024cites this paper
• Strategies for improving the genome-editing efficiency of class 2 CRISPR/Cas system

  2024cites this paper
• DNA base editing corrects common Hemophilia A mutations and restores factor VIII expression in vitro and ex-vivo models.

  2024cites this paper
• Recapitulating familial hypercholesterolemia in a mouse model by knock‐in patient‐specific LDLR mutation

  2024cites this paper
• The Role of CRISPR/Cas9 in Revolutionizing Duchenne's Muscular Dystrophy Treatment: Opportunities and Obstacles

  2024cites this paper
• Targeting the IDH1R132H mutation in gliomas by CRISPR/Cas precision base editing

  2024cites this paper
• Current Knowledge of Base Editing and Prime Editing

  2024cites this paper
• Functional profiling of serine, threonine and tyrosine sites

  2024cites this paper
• Genome editing using type I-E CRISPR-Cas3 in mice and rat zygotes

  2024cites this paper
• Engineered bacterial lipoate protein ligase A (lplA) restores lipoylation in cell models of lipoylation deficiency

  2024cites this paper
• The application of CRISPR/Cas9-based genome-wide screening to disease research.

  2024cites this paper
• A base editor for the long-term restoration of auditory function in mice with recessive profound deafness

  2024cites this paper
• Evaluation of DNA minicircles for delivery of adenine and cytosine base editors using activatable gene on “GO” reporter imaging systems

  2024cites this paper
• Biotechnological applications of purine and pyrimidine deaminases.

  2024cites this paper
• Genome editing: An insight into disease resistance, production efficiency, and biomedical applications in livestock

  2024cites this paper
• Delivery of genetic medicines for muscular dystrophies

  2024cites this paper
• Base editing in humanized dystrophic mice

  2024cites this paper
• Advancements of CRISPR-Mediated Base Editing in Crops and Potential Applications in Populus

  2024cites this paper
• Breaking genetic shackles: The advance of base editing in genetic disorder treatment

  2024cites this paper
• Viral and nonviral nanocarriers for in vivo CRISPR-based gene editing

  2024cites this paper
• CRISPR-Based Gene Therapies: From Preclinical to Clinical Treatments

  2024cites this paper
• Suppressor tRNA in gene therapy

  2024cites this paper
• Development of a universal antibiotic resistance screening system for efficient enrichment of C-to-G and A-to-G base editing.

  2024cites this paper
• Recent Therapeutic Gene Editing Applications to Genetic Disorders

  2024cites this paper
• CRISPR base editing-mediated correction of a tau mutation rescues cognitive decline in a mouse model of tauopathy

  2024cites this paper
• Precision medicine in action for Pompe disease

  2024cites this paper
• Restoring T and B cell generation in X-linked severe combined immunodeficiency mice through hematopoietic stem cells adenine base editing

  2024cites this paper
• The BALB/c.mdx62 mouse exhibits a dystrophic muscle pathology and is a model of Duchenne muscular dystrophy

  2024cites this paper
• Correction of human nonsense mutation via adenine base editing for Duchenne muscular dystrophy treatment in mouse

  2024cites this paper
• Adenine base editing-mediated exon skipping restores dystrophin in humanized Duchenne mouse model

  2024cites this paper
• Comprehensive evaluation and prediction of editing outcomes for near-PAMless adenine and cytosine base editors

  2024cites this paper
• CRISPR technologies for genome, epigenome and transcriptome editing

  2024cites this paper
• Efficient prime editing in two-cell mouse embryos using PEmbryo

  2024cites this paper
• Applications of CRISPR technologies to the development of gene and cell therapy

  2024cites this paper
• An adenine base editor variant expands context compatibility

  2024cites this paper
• Precise genome-editing in human diseases: mechanisms, strategies and applications

  2024cites this paper
• BASE EDITING: A PROMISING TOOL FOR GENETIC MANIPULATION IN MAMMALIAN SOMATIC AND STEM CELL LINES

  2024cites this paper
• CRISPR-mediated ablation of TP53 and EGFR mutations enhances gefitinib sensitivity and anti-tumor efficacy in lung cancer

  2024cites this paper
• Past, present, and future of CRISPR genome editing technologies.

  2024cites this paper
• Production of Duchenne muscular dystrophy cellular model using CRISPR-Cas9 exon deletion strategy

  2023cites this paper
• A systematic review of computational methods for designing efficient guides for CRISPR DNA base editor systems

  2023cites this paper
• Prime editing strategies to mediate exon skipping in DMD gene

  2023cites this paper
• Revolutionizing Genetic Disease Treatment:Recent Technological Advances in Base Editing

  2023cites this paper
• Duchenne muscular dystrophy: disease mechanism and therapeutic strategies

  2023cites this paper
• RNA Transcript Diversity in Neuromuscular Research

  2023cites this paper
• Breakthrough in CRISPR/Cas system: Current and future directions and challenges

  2023cites this paper
• Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox

  2023cites this paper
• Gene editing innovations and their applications in cardiomyopathy research

  2023cites this paper
• Advances in CRISPR/Cas9 Genome Editing for the Treatment of Muscular Dystrophies

  2023cites this paper
• Single-Base Resolution Detection of N6-Methyladenosine in RNA by Adenosine Deamination Sequencing.

  2023cites this paper
• Viral Vectors, Exosomes, and Vexosomes: Potential Armamentarium for Delivering CRISPR/Cas to Cancer Cells.

  2023cites this paper
• PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cells

  2023cites this paper
• Recent advances in therapeutic CRISPR-Cas9 genome editing: mechanisms and applications

  2023cites this paper
• CRISPR-Editing Therapy for Duchenne Muscular Dystrophy

  2023cites this paper
• Single-swap editing for the correction of common Duchenne muscular dystrophy mutations

  2023cites this paper